Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1994 6
1995 15
1996 44
1997 84
1998 165
1999 257
2000 273
2001 344
2002 384
2003 472
2004 488
2005 529
2006 601
2007 543
2008 583
2009 471
2010 508
2011 524
2012 523
2013 546
2014 495
2015 442
2016 440
2017 440
2018 406
2019 412
2020 455
2021 498
2022 482
2023 402
2024 181

Text availability

Article attribute

Article type

Publication date

Search Results

10,842 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for olanzapine
Your search for lanzapine retrieved no results
Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis.
Han R, Bian Q, Chen H. Han R, et al. Brain Behav. 2022 Feb;12(2):e2498. doi: 10.1002/brb3.2498. Epub 2022 Jan 12. Brain Behav. 2022. PMID: 35020271 Free PMC article. Review.
DISCUSSION: Olanzapine showed efficacy in the treatment of AN with an increased BMI at the end of treatment in adults. The effect of olanzapine as adjuvant treatment in adolescents remains unclear....
DISCUSSION: Olanzapine showed efficacy in the treatment of AN with an increased BMI at the end of treatment in adults. The effect of …
Olanzapine/Samidorphan: First Approval.
Paik J. Paik J. Drugs. 2021 Aug;81(12):1431-1436. doi: 10.1007/s40265-021-01568-0. Drugs. 2021. PMID: 34304374 Review.
Samidorphan, which was developed by Alkermes, is an opioid receptor antagonist that has been co-formulated with olanzapine into a single-dose oral tablet to mitigate the risk of weight gain while providing the therapeutic effect of olanzapine. Olanzapine/sami …
Samidorphan, which was developed by Alkermes, is an opioid receptor antagonist that has been co-formulated with olanzapine into a sin …
The pharmacogenetics of treatment with olanzapine.
Zubiaur P, Soria-Chacartegui P, Villapalos-García G, Gordillo-Perdomo JJ, Abad-Santos F. Zubiaur P, et al. Pharmacogenomics. 2021 Sep;22(14):939-958. doi: 10.2217/pgs-2021-0051. Epub 2021 Sep 16. Pharmacogenomics. 2021. PMID: 34528455 Free article.
Genetic polymorphism in olanzapine-metabolizing enzymes, transporters and drug targets is associated with alterations in safety and efficacy. ...DRD2 Taq1A (rs1800497) *A1, LEP -2548 (rs7799039) G and CYP1A2*1F alleles were related to olanzapine effectiveness and sa …
Genetic polymorphism in olanzapine-metabolizing enzymes, transporters and drug targets is associated with alterations in safety and e …
Olanzapine in oncology palliative care.
Šoukalová Z. Šoukalová Z. Klin Onkol. 2022 Summer;35(4):276-283. doi: 10.48095/ccko2022276. Klin Onkol. 2022. PMID: 35989084 Review. English.
BACKGROUND: Olanzapine is an effective antipsychotic drug used in psychiatry to treat psychoses, especially schizophrenia and schizoaffective disorders. ...Olanzapine is an effective treatment for delirium, as effective as haloperidol, but with a lower toxicity prof …
BACKGROUND: Olanzapine is an effective antipsychotic drug used in psychiatry to treat psychoses, especially schizophrenia and schizoa …
Olanzapine-Induced Bradycardia.
Sachdeva V, Ashraf S, Inam S, Shah K, Singla A, Mansuri Z, Jain B. Sachdeva V, et al. Prim Care Companion CNS Disord. 2023 Aug 15;25(4):22cr03453. doi: 10.4088/PCC.22cr03453. Prim Care Companion CNS Disord. 2023. PMID: 37595163 Free article. No abstract available.
Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD. Attia E, et al. Am J Psychiatry. 2019 Jun 1;176(6):449-456. doi: 10.1176/appi.ajp.2018.18101125. Epub 2019 Jan 18. Am J Psychiatry. 2019. PMID: 30654643 Free PMC article. Clinical Trial.
OBJECTIVE: This study evaluated the benefits of olanzapine compared with placebo for adult outpatients with anorexia nervosa. ...RESULTS: Seventy-five participants were assigned to receive olanzapine and 77 to receive placebo. A statistically significant treatment-b …
OBJECTIVE: This study evaluated the benefits of olanzapine compared with placebo for adult outpatients with anorexia nervosa. ...RESU …
The Benefits of Olanzapine in Palliating Symptoms.
Davis MP, Sanger GJ. Davis MP, et al. Curr Treat Options Oncol. 2020 Nov 26;22(1):5. doi: 10.1007/s11864-020-00804-1. Curr Treat Options Oncol. 2020. PMID: 33244634 Review.
Olanzapine has become a major drug in the management of chemotherapy-induced nausea and vomiting as a prophylactic agent. ...The benefits of adding olanzapine to potent opioids are that it may reduce craving, drug cues, and opioid misuse. ...
Olanzapine has become a major drug in the management of chemotherapy-induced nausea and vomiting as a prophylactic agent. ...The bene …
Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial.
Navari RM, Pywell CM, Le-Rademacher JG, White P, Dodge AB, Albany C, Loprinzi CL. Navari RM, et al. JAMA Oncol. 2020 Jun 1;6(6):895-899. doi: 10.1001/jamaoncol.2020.1052. JAMA Oncol. 2020. PMID: 32379269 Free PMC article. Clinical Trial.
After 1 week of treatment, the reduction in nausea scores in the olanzapine arm was 8 points (95% CI, 7-8) higher than that of the placebo arm. ...One patient, on the placebo, stopped treatment early owing to lack of perceived benefit. No patients receiving olanzapine …
After 1 week of treatment, the reduction in nausea scores in the olanzapine arm was 8 points (95% CI, 7-8) higher than that of the pl …
Olanzapine and samidorphan combination treatment: A systematic review.
Jawad MY, Alnefeesi Y, Lui LMW, Ceban F, Chen-Li DCJ, Teopiz K, Jaberi S, Gillissie ES, Vincenzo JDD, Rosenblat JD, McIntyre RS. Jawad MY, et al. J Affect Disord. 2022 Mar 15;301:99-106. doi: 10.1016/j.jad.2022.01.004. Epub 2022 Jan 7. J Affect Disord. 2022. PMID: 35007644 Review.
INTRODUCTION: The overarching aim of this review is to synthesize the efficacy, tolerability, and weight-mitigation effects of the olanzapine/samidorphan (OLZ/SAM) combination treatment in adults with schizophrenia and bipolar disorder-I. ...
INTRODUCTION: The overarching aim of this review is to synthesize the efficacy, tolerability, and weight-mitigation effects of the olanza …
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?
Faden J, Serdenes R, Citrome L. Faden J, et al. Expert Rev Neurother. 2022 May;22(5):365-376. doi: 10.1080/14737175.2022.2060742. Epub 2022 Apr 13. Expert Rev Neurother. 2022. PMID: 35354374 Review.
Olanzapine-samidorphan combination tablets (OLZ/SAM), branded as Lybalvi, is a newly FDA approved formulation aimed at attenuating antipsychotic induced weight gain via modulation of the endogenous opioid system with samidorphan, while retaining the robust antipsychotic ef …
Olanzapine-samidorphan combination tablets (OLZ/SAM), branded as Lybalvi, is a newly FDA approved formulation aimed at attenuating an …
10,842 results
You have reached the last available page of results. Please see the User Guide for more information.